Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Y. Seino"" wg kryterium: Autor


Wyświetlanie 1-8 z 8
Tytuł:
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study.
Autorzy:
Kim DJ; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea.
Sheu WH; Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan.
Chung WJ; Department of Cardiovascular Medicine, Gachon University Gil Medical Center, Incheon, South Korea.
Yabe D; Kansai Electric Power Medical Research Institute, Kobe, Japan.; Department of Diabetes, Metabolism and Endocrinology/Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan.; Center for Healthcare Information Technology, Tokai National Higher Education and Research System, Nagoya, Japan.; Division of Metabolism and Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Ha KH; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea.
Nangaku M; Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan.
Tan EC; National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan.; Institute of Hospital and Healthcare Administration, National Yang-Ming University, Taipei, Taiwan.
Node K; Department of Cardiovascular Medicine, Saga University, Saga, Japan.
Yasui A; Nippon Boehringer Ingelheim Co. Ltd, Tokyo, Japan.
Lei W; Boehringer Ingelheim Taiwan Ltd, Taipei, Taiwan.
Lee S; Boehringer Ingelheim Korea Ltd, Seoul, South Korea.
Saarelainen L; IQVIA, Espoo, Finland.
Deruaz-Luyet A; Boehringer Ingelheim International GmbH, Ingelheim, Germany.
Kyaw MH; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.
Seino Y; Kansai Electric Power Medical Research Institute, Kobe, Japan.; Kansai Electric Power Hospital, Osaka, Japan.
Pokaż więcej
Corporate Authors:
EMPRISE East Asia Study Group
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2023 Mar; Vol. 14 (3), pp. 417-428. Date of Electronic Publication: 2023 Jan 30.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/chemically induced
Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/prevention & control
Cardiovascular Diseases*/chemically induced
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use
Myocardial Infarction*
Humans ; Asia, Eastern/epidemiology ; Hypoglycemic Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Dynamics and source of endothelin-1 and interleukin-6 following coronary reperfusion in patients with acute myocardial infarction.
Autorzy:
Imaizumi T; Division of Intensive and Coronary Care Unit, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan.
Nejima J
Kiuchi K
Takeda S
Seino Y
Tanaka K
Takano T
Pokaż więcej
Źródło:
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi [J Nippon Med Sch] 2007 Apr; Vol. 74 (2), pp. 131-47.
Typ publikacji:
Journal Article
MeSH Terms:
Myocardial Reperfusion*
Endothelin-1/*blood
Interleukin-6/*blood
Myocardial Infarction/*blood
Blood Vessels/metabolism ; Endothelin-1/metabolism ; Female ; Humans ; Interleukin-6/metabolism ; Male ; Myocardial Infarction/physiopathology ; Time Factors
Czasopismo naukowe
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies